Granuloma annulare associated with immune checkpoint inhibitors.
作者信息
Wu J, Kwong B Y, Martires K J, Rieger K E, Chung W H, Iyer G V, Lacouture M E
机构信息
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 60th Street Outpatient Center, Suite 407, Room 4312, New York, NY, 10022, USA.
Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Keelung, Linkou, and Taipei, No. 5, Fuxing Street, Guishan District, Taoyuan City, 333, Taiwan.
出版信息
J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e124-e126. doi: 10.1111/jdv.14617. Epub 2017 Oct 27.
Abstract
摘要
相似文献
1
Granuloma annulare associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的环状肉芽肿。
J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e124-e126. doi: 10.1111/jdv.14617. Epub 2017 Oct 27.
2
Nivolumab-Induced Granuloma Annulare.尼伏鲁单抗诱导的环状肉芽肿。
Cutis. 2021 Jun;107(6):E2-E4. doi: 10.12788/cutis.0281.
3
[Two cases of granuloma annulare under anti-PD1 therapy].[抗PD1治疗下的两例环状肉芽肿]
Ann Dermatol Venereol. 2018 Feb;145(2):116-119. doi: 10.1016/j.annder.2017.11.005. Epub 2017 Dec 6.
4
Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome.纳武单抗诱发的急性脱髓鞘性多发性神经根神经病，酷似吉兰-巴雷综合征。
J Neurol Sci. 2018 Jul 15;390:115-116. doi: 10.1016/j.jns.2018.04.028. Epub 2018 Apr 19.
5
Immune checkpoint therapy in proteinuric kidney disease.蛋白尿性肾病中的免疫检查点疗法。
Eur J Cancer. 2018 May;95:120-122. doi: 10.1016/j.ejca.2018.02.007. Epub 2018 Mar 9.
6
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.利妥昔单抗治疗纳武单抗诱导的大疱性类天疱疮。
JAMA Dermatol. 2017 Jun 1;153(6):603-605. doi: 10.1001/jamadermatol.2017.0091.
7
Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report.纳武单抗治疗继发双侧视神经炎：一例报告
Medicina (Kaunas). 2018 Nov 6;54(5):82. doi: 10.3390/medicina54050082.
8
Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.接受纳武单抗治疗的原发性肺黑色素瘤中的双细胞减少症。
Intern Med. 2019 Mar 15;58(6):827-831. doi: 10.2169/internalmedicine.1011-18. Epub 2018 Nov 19.
9
Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.结节性红斑作为纳武单抗诱导的类结节病反应的初始表现。
J Cutan Med Surg. 2018 Nov/Dec;22(6):627-629. doi: 10.1177/1203475418776934. Epub 2018 May 17.
10
[Immune checkpoint inhibitors and endocrinological side effects].[免疫检查点抑制剂与内分泌副作用]
Ugeskr Laeger. 2017 Dec 4;179(49).
引用本文的文献
1
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.CTLA4和PD1阻断辅助治疗黑色素瘤后出现的肉芽肿性和类结节病样免疫相关不良事件：ECOG-ACRIN E1609和SWOG S1404 III期试验的联合分析及文献综述
Cancers (Basel). 2023 Apr 29;15(9):2561. doi: 10.3390/cancers15092561.
2
Skin Manifestation Induced by Immune Checkpoint Inhibitors.免疫检查点抑制剂诱导的皮肤表现
Clin Cosmet Investig Dermatol. 2022 May 10;15:829-841. doi: 10.2147/CCID.S364243. eCollection 2022.
3
Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report.纳武单抗诱发晚期黑色素瘤患者苔藓样肉芽肿性口腔炎：一例报告
Mol Clin Oncol. 2022 Apr;16(4):79. doi: 10.3892/mco.2022.2512. Epub 2022 Feb 8.
4
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms.环状肉芽肿与 2 型糖尿病、血脂异常、自身免疫性疾病和血液系统恶性肿瘤的相关性。
JAMA Dermatol. 2021 Jul 1;157(7):817-823. doi: 10.1001/jamadermatol.2021.1805.
5
Anti-CTLA-4 therapy-associated granuloma annulare in chronic myelomonocytic leukemia.慢性粒单核细胞白血病中抗CTLA-4治疗相关的环状肉芽肿
Proc (Bayl Univ Med Cent). 2020 Sep 28;34(1):122-123. doi: 10.1080/08998280.2020.1818165.
6
Postherpes zoster programmed death-1 inhibitor-associated zosteriform granulomatous reactions.带状疱疹后程序性死亡-1抑制剂相关的带状疱疹样肉芽肿反应。
JAAD Case Rep. 2020 Oct 7;6(12):1201-1204. doi: 10.1016/j.jdcr.2020.09.017. eCollection 2020 Dec.
本文引用的文献
1
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.一名肺腺癌患者出现的与纳武单抗相关的皮肤结节病。
JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May.
2
Granuloma annulare: Pathogenesis, disease associations and triggers, and therapeutic options.环状肉芽肿：发病机制、疾病相关性和触发因素以及治疗选择。
J Am Acad Dermatol. 2016 Sep;75(3):467-479. doi: 10.1016/j.jaad.2015.03.055.
3
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.针对程序性死亡受体-1（PD-1）受体的药物所致皮肤不良事件的特征与管理
Eur J Cancer. 2016 Jun;60:12-25. doi: 10.1016/j.ejca.2016.02.010. Epub 2016 Apr 1.
4
Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma.在一名对伊匹单抗难治的转移性黑色素瘤患者中，与纳武单抗相关的伴有严重卫星细胞坏死的中毒性表皮坏死松解症样反应。
J Immunother. 2016 Apr;39(3):149-52. doi: 10.1097/CJI.0000000000000112.
5
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.靶向 PD-1 和 PD-L1 的免疫检查点抑制剂相关的自身免疫性大疱性皮肤病。
Cancer Immunol Res. 2016 May;4(5):383-9. doi: 10.1158/2326-6066.CIR-15-0123. Epub 2016 Feb 29.
6
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.纳武利尤单抗用于可切除和不可切除转移性黑色素瘤：免疫相关不良事件的特征及其与预后的关联
Clin Cancer Res. 2016 Feb 15;22(4):886-94. doi: 10.1158/1078-0432.CCR-15-1136. Epub 2015 Oct 7.
7
Granuloma Annulare.环状肉芽肿
Dermatol Clin. 2015 Jul;33(3):315-29. doi: 10.1016/j.det.2015.03.001. Epub 2015 May 13.
8
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.伊匹单抗单药治疗预处理的晚期黑色素瘤患者：一项随机、双盲、多中心、2 期、剂量范围研究。
Lancet Oncol. 2010 Feb;11(2):155-64. doi: 10.1016/S1470-2045(09)70334-1. Epub 2009 Dec 8.
Zotero 插件